Vimarsana
Biggest News Aggregation in the World

Page 15 - Manufacturing Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Manufacturing Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Manufacturing Practice Today - Breaking & Trending Today

Akanda Corp.: Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access - Vimarsana News

Akanda Corp.: Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access

Transformational deal will add prized cultivation, manufacturing and distribution assets to accelerate Akanda's seed-to-patient model and satisfy demand in fast-growing European cannabis markets Akanda

FDAnews Announces Selecting and Implementing Electronic Document Management Systems in the EU Management Report - Vimarsana News

FDAnews Announces Selecting and Implementing Electronic Document Management Systems in the EU Management Report

Falls Church, VA (PRWEB) April 18, 2022 -- Selecting and Implementing Electronic Document Management Systems in the

Source: prweb.com
Cantourage kick-starts business in growing UK medical cannabis market with award of pharmaceutical licences and CQC registration to prescribe to patients - Vimarsana News

Cantourage kick-starts business in growing UK medical cannabis market with award of pharmaceutical licences and CQC registration to prescribe to patients

- British subsidiary of Cantourage receives pharmaceutical licences from Home Office and Medicines and Healthcare products Regulatory Agency - The licences allow Cantourage to import, supply

The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for the First-Line Treatment of Small Cell Lung Cancer Accepted by NMPA - Vimarsana News

The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for the First-Line Treatment of Small Cell Lung Cancer Accepted by NMPA

/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of HANSIZHUANG (serplulimab), a novel anti-PD-1...

Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou - Vimarsana News

Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou

/PRNewswire/ -- The board of directors of Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group",Stock code:2179.HK)...